Clinical Development Network Across Global Newsroom Participants Member Login Submit an RFP

Solutions · Laboratory Services | Clinical Laboratories, Biomarkers and Biospecimen | Guosa Life Sciences

Scientific Precision Supporting Clinical Development

Q: Can you manage biospecimens and biobanking?

Yes, secure biospecimen management, chain-of-custody, and sample logistics are core capabilities.

Laboratory Solutions That Deliver Reliable Results

Laboratory services are fundamental to modern clinical development, providing the scientific evidence that informs safety, efficacy, biomarker evaluation and clinical decision-making.

Submit an RFP

Home/Solutions/Laboratory Services | Clinical Laboratories, Biomarkers and Biospecimen | Guosa Life Sciences

Overview

Laboratory Solutions That Deliver Reliable Results

Reliable laboratory operations require more than analytical capability. They require rigorous quality systems, standardized processes, secure biospecimen management and seamless integration with clinical operations.

Guosa Life Sciences delivers comprehensive laboratory solutions through a network of qualified partners, standardized procedures and coordinated laboratory management supporting Phase I–IV programs.

Clinical laboratory biomarker and biospecimen analysis

Capabilities

What We Deliver

Laboratory Network

Central laboratories
Regional laboratories
Molecular diagnostics
Biomarker analysis

Specimen and Quality

Biospecimen management
Sample logistics coordination
Laboratory quality systems
Data integration with operations

The GLS Advantage

Strengthened by the Whole Enterprise

Every solution delivered by Guosa Life Sciences is strengthened by the broader enterprise. Our operational teams are supported by evidence-based Insights, professional development through GLS Academy, collaborative partnerships within the Clinical Development Network and a quality-driven delivery model, enabling scientifically sound, operationally efficient and scalable solutions.

Explore the Enterprise

Evidence-based Insights
GLS Academy development
Clinical Development Network
Integrated quality systems
Technology-enabled delivery
Global operational reach

The capability

What We Actually Do

We coordinate central and specialty laboratory work: assay selection and validation oversight, biomarker and immunogenicity testing, biospecimen management, kit build and distribution, and chain-of-custody documentation from collection through analysis and long-term storage.

Where a study can use accredited local laboratory capability rather than shipping every sample out, we assess and qualify it. That is not a cost preference. Shorter transit reduces excursion risk, results return faster, and analysis conducted in the population under study is easier to defend scientifically. Where local capability does not meet the assay requirement, we say so and route accordingly.

Regulatory considerations

Sample export, material transfer and the Nagoya Protocol

Sample movement is a regulatory workstream in its own right, not an operational detail. Export of biological material typically requires an export permit issued separately from the trial approval, often by a different office and on its own timeline, and import into the receiving country carries its own requirements. Material transfer agreements must be executed between institutions before the first shipment, and they take longer to negotiate than teams expect because they touch institutional legal, ethics and sometimes government sign-off.

Where a study involves genetic resources or associated traditional knowledge, obligations under the Nagoya Protocol may apply, including prior informed consent and mutually agreed terms on benefit sharing. These need to be resolved at protocol stage. Discovering them at database lock is expensive and, in some jurisdictions, leaves samples that cannot lawfully be analyzed where they sit.

How an engagement runs

The Sequence

1. Laboratory strategy

Assay requirements mapped against central, specialty and qualified local capability, with turnaround and transit risk assessed per country.

2. Set-up

Kit build and distribution, site training on collection and handling, chain-of-custody documentation and permit applications initiated.

3. Conduct

Sample tracking with excursion monitoring, query resolution, and result delivery against agreed turnaround.

4. Close-out

Sample reconciliation, documented destruction or long-term storage per protocol and consent.

What you receive

Deliverables

A laboratory strategy with assay and capability mapping. Permits and material transfer agreements executed before first shipment. Full chain-of-custody records. Sample reconciliation and disposition documentation.

Evidence and context

The Research Behind This Work

Our operating assumptions are published rather than asserted. The Future of Clinical Trials in Africa sets out why study performance is increasingly determined by ecosystem maturity rather than site selection, and The Untapped Advantage makes the case that institutions, not regions, are the right unit of qualification. Both are available in full, with executive briefs for readers who want the argument in a shorter form.

The Future of Clinical Trials in Africa The Untapped Advantage

Clinical Logistics

Cold-chain and sample transport.

Explore

Clinical Operations

Integrated delivery.

Explore

Data and Biostatistics

Lab data integration.

Explore

Oncology

Biomarker-guided trials.

Explore

FAQ

Common Questions

Do you operate your own laboratories?

We coordinate a network of qualified central and regional laboratory partners under standardized procedures and quality oversight, integrated with clinical operations.

Can you manage biospecimens and biobanking?

Yes, secure biospecimen management, chain-of-custody and sample logistics are core capabilities.

Let's Discuss Your Program

Tell us about your objectives and our multidisciplinary team will scope an integrated, flexible solution.

Submit an RFP

Scientific Precision Supporting Clinical Development

Laboratory Solutions That Deliver Reliable Results

What We Deliver

Laboratory Network

Specimen and Quality

Strengthened by the Whole Enterprise

What We Actually Do

Sample export, material transfer and the Nagoya Protocol

The Sequence

1. Laboratory strategy

2. Set-up

3. Conduct

4. Close-out

Deliverables

The Research Behind This Work

Explore Related Capabilities

Clinical Logistics

Clinical Operations

Data and Biostatistics

Oncology

Common Questions

Let's Discuss Your Program